✦ LIBER ✦

CLOPIDOGREL: THE FUTURE CHOICE FOR PREVENTING PLATELET ACTIVATION DURING CORONARY STENTING?

✍ Scribed by PAUL A. GURBEL; CHRISTOPHER M. O'CONNOR; CHARLES C. CUMMINGS; VICTOR L. SEREBRUANY

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Heparin Prevents Xylum Clot Signature An

✍ Victor L. Serebruany; Alex I. Malinin; Christopher R. Bell; Paul A. Gurbel 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Clinical relevance of clopidogrel unresp

✍ Catherine M. Moerenhout; Marc J. Claeys; Steven Haine; Hielko Miljoen; Johan M. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 122 KB

The importance of IVUS guidance during c

✍ R. Torguson; P. Roy; Z. Xue; K. Smith; T.L. Pinto Slottow; L.F. Satler; K.M. Ken 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Residual platelet activity in patients m

✍ João Morais 📂 Article 📅 2012 🏛 Elsevier ⚖ 120 KB

Usefulness of Platelet Response to Clopi

✍ Giuseppe Patti; Vincenzo Pasceri; Vincenzo Vizzi; Elisabetta Ricottini; Germano 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 689 KB

Point-of-Care Measurement of Clopidogrel

✍ Giuseppe Patti; Annunziata Nusca; Fabio Mangiacapra; Laura Gatto; Andrea D'Ambro 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 301 KB